Iron in the Brain: An Important Contributor in Normal and Diseased States
- 1 December 2000
- journal article
- Published by SAGE Publications in The Neuroscientist
- Vol. 6 (6) , 435-453
- https://doi.org/10.1177/107385840000600607
Abstract
Iron is essential for normal neurological function because of its role in oxidative metabolism and because it is a cofactor in the synthesis of neurotransmitters and myelin. In the past several years, there has been increased attention to the importance of oxidative stress in the central nervous system. Iron is the most important inducer of reactive oxygen species, therefore, the relation of iron to neurodegenerative processes is more appreciated today than it was a few years ago. Nevertheless, despite this increased attention and awareness, our knowledge of iron metabolism in the brain at the cellular and molecular levels is still limited. Iron is distributed in a heterogeneous fashion among the different regions and cells of the brain. This regional and cellular heterogeneity is preserved across many species. Brain iron concentrations are not static; they increase with age and in many diseases and decrease when iron is deficient in the diet. In infants and children, insufficient iron in the diet is associated with decreased brain iron and with changes in behavior and cognitive functioning. Abnormal iron accumulation in the diseased brain areas and, in some cases, alterations in iron-related proteins have been reported in many neurodegenerative diseases, including Hallervorden-Spatz syndrome, Alzheimer’s disease, Parkinson’s disease, and Friedreich’s ataxia. There is strong evidence for iron-mediated oxidative damage as a primary contributor to cell death in these disorders. Demyelinating diseases, such as multiple sclerosis, especially warrant study in relation to iron availability. Myelin synthesis and maintenance have a high iron requirement, thus, oligodendrocytes must have a relatively high and constant supply of iron. However, the high oxygen utilization, high density of lipids, and high iron content of white matter all combine to increase the risk of oxidative damage. We review here the current knowledge of the normal metabolism of iron in the brain and the suspected role of iron in neuropathology.Keywords
This publication has 187 references indexed in Scilit:
- Developmental changes in transferrin and iron uptake by the brain in the ratPublished by Elsevier ,2003
- Reversal of developmental delays in iron-deficient anaemic infants treated with ironThe Lancet, 1993
- Iron deficiency of liver, heart, and brain in newborn infants of diabetic mothersThe Journal of Pediatrics, 1992
- Different forms of post-training memory processingBehavioral and Neural Biology, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patientsNeurochemical Research, 1985
- Expression of the transferrin gene during development of non-hepatic tissues: High level of transferrin mRNA in fetal muscle and adult brainBiochemical and Biophysical Research Communications, 1984
- The effects of therapy on the developmental scores of iron-deficient infantsThe Journal of Pediatrics, 1978
- Distribution of metal ions in the subcellular fractions of several rat brain areasLife Sciences, 1976
- An X-ray scattering study of ferritin and apoferritinJournal of Molecular Biology, 1965